Deep Dive: Procalcitonin

rawpixel-600792-unsplash.jpg

Background:

  • Procalcitonin is an acute phase reactant that is a propeptide processed into the hormone calcitonin

  • When you aren’t sick your body produces procalcintonin from the thyroid

  • We don’t know what its role in healthy patients are except as a precursor to calcitonin

  • A wide range of tissues produce procalitonin in infection

  • We still don’t know what it’s role in the body’s response to infection is

  • elevated somewhere between 2-12 hours after bacterial infection

  • Peak levels are typically reached at 24-48 hours after bacterial infection

  • broken down from peptide to an amino acid by enzymes

Why does it matter?

  • Reduce antibiotic use

    • A global health priority by numerous organizations

  • Providers still giving antibiotics for bronchitis and similar diseases despite CDC recommendations against it

Procalcitonin Use in LRTI’s (CAP, Bronchitis, COPD AE)

  • ProHOSP the initial trial published in JAMA 2009 that created the procalcitonin guidelines we still use

Large Cochrane review by Dr. Scheutz which was revised in 10/2017. High quality of evidence for mortality and reduction of antibiotic exposure in acute LRTI’s

Large Cochrane review by Dr. Scheutz which was revised in 10/2017. High quality of evidence for mortality and reduction of antibiotic exposure in acute LRTI’s

Screen Shot 2018-12-04 at 11.04.41 AM.png

  1. Alba GA, Truong QA, Gaggin HK, et al. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea. Am J Med 2016; 129:96.

  2. Wang W, Zhang X, Ge N, et al. Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases. Crit Care 2014; 18:R4.

  3. Maisel A, Neath SX, Landsberg J, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail 2012; 14:278.

 

Bottom line:

Don’t Use PCT to Withhold or Stop Antibiotics in Severe COPD AE going to ICU

https://link.springer.com/article/10.1007%2Fs00134-018-5141-9

PCT and Sepsis: Abx Discontinuation

  • Do not use to determine initiation of antibiotics in sepsis

  • Can be used to guide antibiotic discontinuation in sepsis (SAPS)

    • Number is < 0.5 in Sepsis (0.25 in LRTI)

PCT and Sepsis: Risk Assessment

  • Independent predictor of mortality (MOSES Study CCM 5/2017)

    • Used by Paul Marik to determine who got Marik Protocol in that famous study

  • Reduction of PCT by 80% in 72 hours shows treatment effectiveness in sepsis and the lack of 80% reduction or increase in PCT indicates treatment failure.

New Study: ProACT:

  • Large, multicenter RCT, > 1600 patients at 14 academic centers

  • They looked specifically at patients that presented to the ED with a suspected LRTI and for whom the treating physician was uncertain whether abx therapy was indicated

  • primary endpoints were antibiotic days and percentage of patients with adverse outcomes

  • No reduction in antibiotic days (4.2 vs 4.3) and no difference in adverse events

  • Clinicians adhered to the PCT guideline recommendation 73% of the time in the PCT group

  • CAP had the lowest adherence at 39%

  • study did not force clinicians in the PCT group to stop abx based on the PCT level

  • hospitals with excellent pneumonia quality metrics

What else can elevate PCT?

  • Cancer

    • Medullary thyroid carcinoma or islet cell tumors can have elevations in PCT > 10,000

  • Trauma, burns, multiorgan failure, and recent major surgery

  • patients with ESRD who haven’t had regular dialysis treatments in a few days can have elevated PCT levels without an infection

  • pancreatitis, prolonged cardiogenic shock, MODS, autoimmune disorders, liver dysfunction or recent liver transplant, prolonged arrest and resuscitation, and rhabdo

Guidelines:

FDA Executive Summary:

  • FDA recommendations which were expanded for PCT in February 2017.

  • It is recommended to be used when starting and stopping antibiotics in community acquired LRTIs

  • Recommended to be used in stopping antibtiocs in sepsis.

  • It was initially recommendation was to assess mortality in sepsis

2016 IDSA Antimicrobial Stewardship Guidelines: weak recommendation

2018 Surviving Sepsis Campaign: weak recommendation

2016 IDSA/ATS HAP/VAP Guidelines: weak recommendation for discontinuation, do not use for initiation

2007 IDSA CAP Guidelines: currently refreshing

PCT infographic.png

Attributions

"Reddit”, “Breezin”, “Filaments”, “Am-Trans” and “Squirrel Commotion” by Podington Bear is licensed under CC BY-NC 3.0 / Songs have been cropped in length from original form

Lee Corso “Not so fast” via youtube

Rachel F

Rachel is a physician assistant who has been holding down the ICU since 2016. She joined the Pulmcast podcast in 2017 and has been hooked on FOAMed ever since. Rachel has a passion for teaching using technology with a special focus on preserving dignity in the ICU. When she's not at work, you’ll find her playing with her golden retriever, hunting for thrift store treasures, and soaking up time with her husband and son.

Previous
Previous

Deep Dive: GI Bleeds and Hemorrhagic Shock

Next
Next

ABG Jujitsu